Capital Investment Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $383K | Buy |
2,087
+86
| +4% | +$15.8K | 0.01% | 540 |
|
|
2025
Q4 | $352K | Sell |
2,001
-144
| -7% | -$23.5K | 0.01% | 551 |
|
|
2025
Q3 | $301K | Sell |
2,145
-19
| -0.9% | -$2.57K | ﹤0.01% | 588 |
|
|
2025
Q2 | $272K | Buy |
2,164
+111
| +5% | +$13.8K | ﹤0.01% | 596 |
|
|
2025
Q1 | $281K | Buy |
2,053
+1
| +0% | +$143 | 0.01% | 566 |
|
|
2024
Q4 | $314K | Sell |
2,052
-169
| -8% | -$28.5K | 0.01% | 510 |
|
|
2024
Q3 | $431K | Buy |
2,221
+24
| +1% | +$5.02K | 0.01% | 436 |
|
|
2024
Q2 | $509K | Buy |
2,197
+321
| +17% | +$69.8K | 0.01% | 392 |
|
|
2024
Q1 | $405K | Sell |
1,876
-126
| -6% | -$29.5K | 0.01% | 432 |
|
|
2023
Q4 | $518K | Sell |
2,002
-3
| -0.1% | -$737 | 0.01% | 377 |
|
|
2023
Q3 | $515K | Buy |
2,005
+12
| +0.6% | +$3.21K | 0.01% | 353 |
|
|
2023
Q2 | $568K | Sell |
1,993
-1
| -0.1% | -$298 | 0.02% | 323 |
|
|
2023
Q1 | $554K | Buy |
1,994
+7
| +0.4% | +$1.94K | 0.02% | 337 |
|
|
2022
Q4 | $550K | Buy |
1,987
+138
| +7% | +$39K | 0.02% | 345 |
|
|
2022
Q3 | $494K | Sell |
1,849
-155
| -8% | -$32.9K | 0.02% | 341 |
|
|
2022
Q2 | $409K | Sell |
2,004
-117
| -6% | -$23.9K | 0.01% | 369 |
|
|
2022
Q1 | $447K | Sell |
2,121
-365
| -15% | -$79.4K | 0.01% | 379 |
|
|
2021
Q4 | $596K | Sell |
2,486
-130
| -5% | -$33.4K | 0.02% | 347 |
|
|
2021
Q3 | $740K | Sell |
2,616
-484
| -16% | -$159K | 0.02% | 313 |
|
|
2021
Q2 | $1.07M | Sell |
3,100
-311
| -9% | -$94.2K | 0.04% | 255 |
|
|
2021
Q1 | $954K | Sell |
3,411
-163
| -5% | -$44K | 0.04% | 264 |
|
|
2020
Q4 | $875K | Sell |
3,574
-508
| -12% | -$131K | 0.04% | 260 |
|
|
2020
Q3 | $1.16M | Sell |
4,082
-120
| -3% | -$33.5K | 0.06% | 199 |
|
|
2020
Q2 | $1.12M | Buy |
4,202
+239
| +6% | +$71.8K | 0.06% | 191 |
|
|
2020
Q1 | $1.25M | Sell |
3,963
-886
| -18% | -$269K | 0.08% | 172 |
|
|
2019
Q4 | $1.44M | Sell |
4,849
-513
| -10% | -$142K | 0.07% | 184 |
|
|
2019
Q3 | $1.25M | Buy |
5,362
+830
| +18% | +$193K | 0.07% | 197 |
|
|
2019
Q2 | $1.06M | Buy |
4,532
+3,547
| +360% | +$819K | 0.06% | 218 |
|
|
2019
Q1 | $233K | Sell |
985
-51
| -5% | -$16.1K | 0.01% | 426 |
|
|
2018
Q4 | $312K | Buy |
1,036
+4
| +0.4% | +$1.28K | 0.02% | 361 |
|
|
2018
Q3 | $365K | Sell |
1,032
-120
| -10% | -$41.3K | 0.02% | 355 |
|
|
2018
Q2 | $334K | Buy |
1,152
+140
| +14% | +$39.4K | 0.02% | 372 |
|
|
2018
Q1 | $277K | Buy |
+1,012
| New | +$314K | 0.02% | 400 |
|
|
2017
Q4 | – | Sell |
-1,228
| Closed | -$385K | – | 487 |
|
|
2017
Q3 | $385K | Buy |
1,228
+218
| +22% | +$64.6K | 0.03% | 328 |
|
|
2017
Q2 | $274K | Buy |
1,010
+65
| +7% | +$17.2K | 0.02% | 380 |
|
|
2017
Q1 | $259K | Buy |
945
+186
| +25% | +$52.6K | 0.02% | 384 |
|
|
2016
Q4 | $215K | Buy |
+759
| New | +$225K | 0.02% | 402 |
|
Other funds holding BIIB
VCM
VPM
Capital Investment Advisors's BIIB Position: Q1 2026 in Review
Capital Investment Advisors increased its Biogen (BIIB) stake by 4.3% in Q1 2026, buying an estimated $15.8K and bringing the position to 2,087 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #540.
Capital Investment Advisors first reported a position in BIIB in Q4 2016 and has held it in 37 quarters since. The position peaked at $1.44M in Q4 2019. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Capital Investment Advisors held 2,087 shares of Biogen worth $383K as of Q1 2026.
- Capital Investment Advisors bought 86 Biogen shares in Q1 2026, an estimated $15.8K.
- Biogen made up 0.01% of Capital Investment Advisors's portfolio in Q1 2026, its #540 holding.
- Capital Investment Advisors first reported a position in Biogen in Q4 2016 and has held it in 37 quarters since.
- Capital Investment Advisors's Biogen position peaked at $1.44M in Q4 2019.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.